AutoBio bridges preclinical science and clinical development by translating mechanistic hypotheses into clinically relevant rationale. The platform connects biology, target validation, and early data into structured transition narratives.

Experts shape interpretation — deciding what carries forward, what must be reframed, and where claims should narrow as programs enter human studies. This ensures continuity without overstating early promise.

Typical Outputs

• Preclinical-to-clinical transition narrative

• Clinical rationale framing document

• Claim narrowing and continuity guidance

• Internal transition alignment materials

• Transition risk and credibility assessment

Primary Users

• Translational Medicine teams converting mechanistic rationale into clinical intent

• Early clinical teams aligning study hypotheses and endpoints to scientific framing

• Medical Affairs leaders preparing first-in-human narratives for scientific exchange

• Governance committees evaluating readiness based on credibility and continuity of claims